2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
G

2020 ASCO Update on Phase III Ovarian Cancer: What Is the Impact of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Gerardo Colon-Otero
By 2020 ASCO Virtual Direct™ Highlights FEATURING Gerardo Colon-Otero
12 views
July 29, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:59
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
GYN
11:40
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Phase III Ovarian Cancer: What Is the Impact of …

Feat. G. Colon-Otero
09:07
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on OS Data for Recent FDA Approved Olaparib

Feat. G. Colon-Otero
07:12
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Ovarian Cancer: Do TKI Cediranib and Olaparib Ha…

Feat. G. Colon-Otero
04:47
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update: Will Sentinel Node Biopsy Replace Pelvic Node Diss…

Feat. G. Colon-Otero
12:42
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Ovarian Q & A: Does Cediranib Have a Future In Ovarian…

Feat. G. Colon-Otero